Pathological Gambling Clinical Trial
— TRAIN-ONLINEOfficial title:
Cognitive Control Training in Online Problem Gambling: an Online Randomized Controlled Trial Among Non-treatment Seeking Problem Gamblers
Verified date | February 2024 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
An online single blinding, randomized, comparative therapeutic web-based, controlled trial. The main objective of the study is to assess the clinical efficacy of an online computerized cognitive training program targeted on cognitive control, namely on inhibition, measured with the PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks, as compared to a control program with a similar setting.
Status | Active, not recruiting |
Enrollment | 200 |
Est. completion date | March 2024 |
Est. primary completion date | June 6, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria 1. Over 18 years old gamblers 2. Willing to share his/her first name, last name, exact birthdate, and exact place of birth (city + department). These informations are needed to extract ARJEL player account based gambling data, to avoid any doubloon or homonym. 3. PGSI-recent = 5. 4. Recipient or beneficiary of the French social security system and resident in France. Non-inclusion criteria 1. Gamblers cannot speak or understand French |
Country | Name | City | State |
---|---|---|---|
France | Paul Brousse Hospital | Villejuif |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris | ARJEL (Autorité de Régulation des Jeux En Ligne) |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The change over 6 weeks in Problem gambling severity index (PGSI)-recent total score, collected by internet | PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks | Change from baseline at 6 weeks | |
Secondary | Problem gambling severity index - recent (PGSI) | Between baseline (T0) , and 14 weeks (T2) | ||
Secondary | Short form of Urgency, Premeditation, Perseverance, Sensation seeking, and Positive urgency (UPPS-P) Impulsive behavior scale | Impulsivity scale | Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2) | |
Secondary | Time Line Follow Back (TLFB) -gambling | Money and time spent gambling including offline gambling | Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2) | |
Secondary | EuroQol five dimensions questionnaire (EQ-5D) | Health related quality of life self-questionnaire | Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2) | |
Secondary | Gambling Quality of Life Scale (GQoLS) | Health related quality of life self-questionnaire specific to gambling disorder | Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2) | |
Secondary | Neuropsychological assessment: Stop Signal Task (SST) | Cognitive task assessing inhibition | Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2) | |
Secondary | Total Deposit | Total Deposit assessed by the account player based gambling data (ARJEL database) | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Total stake by game | Total stake by game assessed by the account player based gambling data (ARJEL database) | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Compulsivity | Compulsivity (as defined by three consecutive deposits in a 12-hour period of time) assessed by the account player based gambling data (ARJEL database) | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Number of deposit in the hour following a stake | Number of deposit in the hour following a stake assessed by the account player based gambling data (ARJEL database) | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Total loss by game | Total loss by game assessed by the account player based gambling data (ARJEL database) | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Number of sessions (all games) | Number of sessions (all games) in a clinical meaning assessed by the account player based gambling data (ARJEL database) Session is defined as gambling behaviour in itself; we'll consider the beginning of a session when a gambling action occurs after no gambling action since at least 30 minutes, and the end of the gambling session a gambling action followed by no gambling action during 30 minutes. | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Session duration (poker only) | Session duration (poker only) assessed by the account player based gambling data (ARJEL database) | In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Gambling time slot | Gambling time slot assessed by the account player based gambling data (ARJEL database).
The time slots are divided as follows: 0:00 to 3 :59 4:00 to 7:59 8:00 to 11:59 12:00 to 15:59 16:00 to 19:59 20:00 to 23:59 |
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3) | |
Secondary | Acceptability of the online program assessed by the number of training session | At 6 week (T1) | ||
Secondary | Acceptability of the online program assessed by the length of training session | At 6 week (T1) | ||
Secondary | Level of guidance assessed by the number of phone session | Number of debriefing by phone sessions | At 6 week (T1) | |
Secondary | Level of guidance assessed by the length of phone session | Length of debriefing by phone sessions | At 6 week (T1) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02590211 -
Poker, Skills and Associated Problems
|
N/A | |
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Enrolling by invitation |
NCT03464838 -
Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Withdrawn |
NCT01340274 -
Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling
|
Phase 2 | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Recruiting |
NCT01154712 -
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
|
Phase 1 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 |